Phase II clinical trial evaluating the efficacy and safety of HRS-7249 and SHR-1918 in patients with severe hypertriglyceridemia at high risk of acute pancreatitis
Understand the research procedures and methods, voluntarily participate in this trial, and sign the informed consent form in writing;
Male or female aged ≥18 years and <80 years on the day of signing the informed consent form.
History of gallstones at the time of screening or previously (except for patients who had their gallbladder removed more than 3 months ago);
Acute pancreatitis that has clinically recovered ≤4 weeks before screening or randomization;
Malignant tumor within 5 years before screening or randomization (except for non-melanoma skin cancer or cervical carcinoma in situ that has been radically treated);
Grade 3/4 heart failure at the time of screening or before randomization;